XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

A year on, Intel's touted chip deals have fallen short



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>A year on, Intel's touted AI-chip deals have fallen short</title></head><body>

Intel scrapped $500 million Gaudi chip sales forecast for 2024

CEO attributes slower uptake to software, chip transition

Analysts question Intel's AI strategy, competitive position

By Jeffrey Dastin

Nov 1 (Reuters) -Intel's INTC.O upbeat revenue projections on Thursday masked a sore point for the embattled company: chips touted for artificial intelligence have not lived up to sales expectations.

The chipmaker scrapped its recent forecast that in 2024 it would sell more than $500 million worth of Gaudi accelerator chips, so called because they speed up the performance of AI applications.

In a call with analysts, CEO Pat Gelsinger attributed their slower uptake to software related to Gaudi and a recent transition from the second to third generation of the chip.

The disappointment underscores Intel's persistent AI travails, years after it declined to pick one strategy that could counter its skyrocketing rival Nvidia NVDA.O. It also shows challenges Intel has faced in delivering on a promise to investors.

After the late 2022 launch of viral ChatGPT, powered by Nvidia GPUs, Gelsinger hoped Intel's AI chips could win new business.

When teams at Intel predicted they could sell at most $500 million, Gelsinger told his executives the figure was not high enough, according to a Reuters special report published Tuesday.

Intel had to project at least $1 billion when Nvidia’s comparable sales were much higher, a source cited Gelsinger as saying. The company did so: in July 2023, Gelsinger touted a more than $1 billion "pipeline of opportunities" led by Gaudi.

Intel at the time had not secured enough supply from the contract chipmaker TSMC 2330.TW to meet the target, two sources told Reuters.

In an earlier statement, Intel said Gelsinger's comments reflected prospective deals accurately.

"No company converts 100% of its pipeline into revenue," Intel said. "We make no apologies for setting ambitious internal targets for our teams – and we will always try to exceed the goals we set for ourselves."

By January this year, Intel told investors more than $2 billion in AI-chip deals were possible. In April, Gelsinger said he expected over $500 million in such AI revenue in 2024. On Thursday, he said he scrapped the forecast.

"Taking a longer-term view, we remain encouraged by the market available to us," Gelsinger said.

Analysts did not mince words.

Vivek Arya of Bank of America asked Gelsinger what business looked like for Intel if its CPU chips, or central processing units, became commoditized and "if there is no competitive AI product?"

"What is Intel's AI strategy right now?" Arya asked.

Gelsinger said CPUs are playing an increasing role in data centers for AI, and customers were showing "good early interest" in Gaudi. Benchmarks for the chip's third generation were impressive, he said.

Overall, Intel reported third-quarter revenue of $13.3 billion, exceeding analysts' estimates. It posted a $16.6 billion loss attributable to the company, after impairment and restructuring charges.

For Michael Ashley Schulman, chief investment officer of Running Point Capital, Intel's cost-cutting and high-growth focus showed it could rebound.

But he had doubts.

"The concern is that Pat Gelsinger may be exaggerating prospects and progress," Schulman said. Intel's CEO, he said, "may not have as tight of control on operational levers and customer fidelity as he needs."



Reporting by Jeffrey Dastin and Max Cherney in San Francisco; Arsheeya Bajwa in Bangalore; Editing by Sam Holmes

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques